Recent Finacing
Recent Raise
Stoke Therapeutics develops antisense oligonucleotide therapies using its TANGO platform to upregulate gene expression by modulating RNA splicing for monogenic and organ-specific disorders (CNS, eye, ear, liver, kidney).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Stoke Therapeutics.
